分期

如果您被确诊患有皮肤 T 细胞淋巴瘤(CTCL),下一步是查明癌症的扩散程度和位置。这称为分期。医务人员可能会利用影像学检查和活检,通过观察癌症病灶的大小、位置以及从原发部位扩散的距离来确定分期。医护团队会根据分期制定您的治疗计划。

不同类型的皮肤 T 细胞淋巴瘤的分期方式并不完全相同。CTCL 的分期通常为 1 至 4 期,用于描述癌症累及皮肤、淋巴结和器官的范围。对于蕈样肉芽肿和塞扎里综合征,分期还用于描述癌症对血液的累及情况。分期数值越高,代表癌症进展程度越严重。

  • 皮肤。 较低的分期数值通常意味着癌症仅局限于较小的皮肤区域。随着分期数值的增加,癌症可能会进展到更大范围的皮肤,或在皮肤上形成肿瘤。较高的分期还意味着癌症已经扩散到身体的其他部位。
  • 淋巴结。 随着分期数值的增加,意味着可能有更多的淋巴结受到累及。较高的分期还可能意味着受累淋巴结位于体内更深处的部位。
  • 器官。 较高的分期通常意味着癌症已扩散到皮肤和淋巴结以外的其他器官。
April 29, 2026

Living with 皮肤 T 细胞淋巴瘤?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

sandramgus
Diagnosed: MGUS

183 Replies Mon, Aug 24, 2026

dburkert
Looking for information about T cell large granulocytic leukemia

34 Replies Sat, Aug 22, 2026

See more discussions
  1. DeVita VT Jr, et al., eds. Cutaneous lymphomas. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Wolters Kluwer; 2023. Accessed Jan. 30, 2026.
  2. Primary cutaneous lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelinesdetail?category=1&id=1491. Accessed Oct. 7, 2024.
  3. AskMayoExpert. Mycosis fungoides and Sezary syndrome (adult). Mayo Clinic; 2024.
  4. Cutaneous T-cell lymphoma in adult. VisualDx. https://www.visualdx.com. Accessed Nov. 7, 2024.
  5. Cutaneous T-cell lymphoma. American Academy of Dermatology. https://www.aad.org/public/diseases/a-z/ctcl-overview. Accessed Nov. 11, 2024.
  6. Cutaneous T-cell lymphoma. Leukemia & Lymphoma Society. https://www.lls.org/publications?field_booklets_language_target_id_1=351&field_booklets_category_target_id=344&sort_by=title&view-type=card. Accessed Nov. 11, 2024.
  7. Niederhuber JE, et al., eds. Cutaneous T-cell lymphoma and cutaneous B-cell lymphoma. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  8. Lavin L, et al. Cutaneous T cell lymphoma following dupilumab therapy in patients with atopic dermatitis: Clinical review and recommendations. American Journal of Clinical Dermatology. 2025; doi:10.1007/s40257-025-00955-7.
  9. Mycosis fungoides and other cutaneous T-cell lymphomas treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/hp/mycosis-fungoides-treatment-pdq. Accessed Jan. 30, 2026.
  10. Hoppe R, et al. Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  11. Freedman S, et al. Clinical manifestations, pathologic features, and diagnosis of subcutaneous panniculitis-like T cell lymphoma. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  12. Elsevier Point of Care. Clinical Overview: Cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome). https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  13. Willemze R. Primary cutaneous T cell lymphomas, rare subtypes. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2026.
  14. Cutaneous lymphomas. National Comprehensive Cancer Care Network.https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1549. Accessed Jan. 30, 2026.
  15. Salama M, et al., eds. Indolent and aggressive mature T-cell and natural killer-cell lymphomas. In: Atlas of Diagnostic Hematology. Elsevier; 2026. https://www.clinicalkey.com. Accessed Jan. 30, 2026.
  16. American College of Surgeons. Primary cutaneous lymphomas. In: AJCC Cancer Staging System. American College of Surgeons; 2026. https://online.statref.com. Accessed Jan. 29, 2026.

相关

产品与服务